Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

3.6K
Commitment is the  process whereby stem cells:
3.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.5K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.5K
Hematopoiesis01:21

Hematopoiesis

7.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.

JCI insight·2024
Same author

Comparative transcriptomic analysis of Illumina and MGI next-generation sequencing platforms using RUNX3- and ZBTB46-instructed embryonic stem cells.

Frontiers in genetics·2024
Same author

Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.

Cell death & disease·2023
Same author

Extensive proteome and functional genomic profiling of variability between genetically identical human B-lymphoblastoid cells.

Scientific data·2022
Same author

Cells Lacking PA200 Adapt to Mitochondrial Dysfunction by Enhancing Glycolysis via Distinct Opa1 Processing.

International journal of molecular sciences·2021
Same author

The transcription factor EGR2 is the molecular linchpin connecting STAT6 activation to the late, stable epigenomic program of alternative macrophage polarization.

Genes & development·2020

Related Experiment Video

Updated: Nov 4, 2025

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
14:37

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

11.3K

Zbtb46-dependent altered developmental program in embryonic stem cell-derived blood cell progenitors.

Pal Boto1,2, Timea Beatrix Gerzsenyi1, Adel Lengyel1

  • 1Stem Cell Differentiation Laboratory, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Stem Cells (Dayton, Ohio)
|May 31, 2021
PubMed
Summary

Zbtb46 transcription factor suppresses early myeloid cell development from embryonic stem cells. It also promotes erythroid cell differentiation, diverting mesodermal cells towards an erythroid pathway.

Keywords:
Zbtb46embryonic stem cellerythropoiesishematopoietic developmenttranscription factor

More Related Videos

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

9.7K
Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.4K

Related Experiment Videos

Last Updated: Nov 4, 2025

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
14:37

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

11.3K
Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

9.7K
Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.4K

Area of Science:

  • Hematopoiesis and Stem Cell Biology
  • Molecular and Cellular Biology
  • Developmental Biology

Background:

  • Zbtb46 is a dendritic cell (DC)-specific transcription factor with largely unknown biological functions.
  • While highly expressed in conventional DCs, Zbtb46 is also found in erythroid progenitors and endothelial cells, suggesting a role in early hematopoietic development.
  • Understanding Zbtb46's role is crucial for deciphering hematopoietic regulatory networks.

Purpose of the Study:

  • To investigate the effect of Zbtb46 on embryonic stem cell (ESC)-derived blood cell progenitors.
  • To elucidate the molecular mechanisms underlying Zbtb46's influence on early hematopoiesis.
  • To explore the potential of Zbtb46 in directing cell fate decisions during differentiation.

Main Methods:

  • Utilized chemically inducible mouse cell lines for forced expression of Zbtb46 in ESCs.
  • Analyzed effects on mesoderm formation, cell proliferation, and myeloid progenitor generation (CD11b+).
  • Conducted gene expression profiling to identify affected myeloid and immune response genes (e.g., Irf8).

Main Results:

  • Forced Zbtb46 expression broadly repressed early ESC differentiation, impacting mesoderm formation and proliferation.
  • Reduced generation of CD11b+ myeloid cells and decreased expression of myeloid-related genes were observed.
  • Conversely, Zbtb46 overexpression enhanced erythroid colony formation, increased adult hemoglobin (Hbb-b1) expression, and elevated CD105+ cells.

Conclusions:

  • Zbtb46 suppresses ESC-derived myeloid development and redirects mesodermal progenitors towards erythroid differentiation.
  • The findings reveal a novel role for Zbtb46 in regulating hematopoietic lineage commitment.
  • Transcriptomic data provide a valuable resource for studying the Zbtb46 regulatory network in progenitor cells.